Zollinger-Ellison syndrome: Difference between revisions

(Created page with "==Background== *aka S-E syndrome *gastric neuroendocrine malignancy results in hypersecretion of hydrochloric acid by parietal cells ==Clinical Features== *Hematemesis *Chron...")
 
No edit summary
Line 2: Line 2:
*aka S-E syndrome
*aka S-E syndrome
*gastric neuroendocrine malignancy results in hypersecretion of hydrochloric acid by parietal cells
*gastric neuroendocrine malignancy results in hypersecretion of hydrochloric acid by parietal cells
*Associated with peptic ulcers and diarrhea
*60% malignant, only 20% resectable; 25% of gastrinoma patients have multiple endocrine neoplasia type I; >80% of gastrinomas found in gastrinoma triangle.


==Clinical Features==
==Clinical Features==

Revision as of 20:50, 27 February 2021

Background

  • aka S-E syndrome
  • gastric neuroendocrine malignancy results in hypersecretion of hydrochloric acid by parietal cells
  • Associated with peptic ulcers and diarrhea
  • 60% malignant, only 20% resectable; 25% of gastrinoma patients have multiple endocrine neoplasia type I; >80% of gastrinomas found in gastrinoma triangle.

Clinical Features

  • Hematemesis
  • Chronic diarrhea
  • Postprandial abdominal pain
  • Nausea
  • Wheezes on auscultation
  • Evidence of malnourishment and decreased oral intake

Differential Diagnosis

Evaluation

Workup

Diagnosis

Management

Disposition

See Also

External Links

References